Patient-reported outcomes in patients with resected, high-risk melanoma with BRAFV600E or BRAFV600K mutations treated with adjuvant dabrafenib plus trametinib (COMBI-AD): a randomised, placebo-controlled, phase 3 trial
| Image |  |
|---|---|
| Description | scientific article published on 27 March 2019 |
| Author/s |
author: Georgina V. Long Bijoyesh Mookerjee Thierry Lesimple Laurent Mortier Mario Santinami Richard F. Kefford Mario Mandala Marta Nyakas Ruth Plummer Andrew Haydon Jacob Schachter Vanna Chiarion Sileni Caroline Dutriaux Axel Hauschild Reinhard Dummer Dirk Schadendorf |
| Publication date | March 27, 2019 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |